Gaurav Goparaju
Stock Analyst at Berenberg
(0.12)
# 3,331
Out of 4,422 analysts
8
Total ratings
11.11%
Success rate
-22.26%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Initiates: Buy | $27 | $41.40 | -34.78% | 1 | Sep 27, 2023 | |
| EXAI Exscientia | Initiates: Buy | $13 | $4.68 | +177.78% | 1 | Jul 21, 2023 | |
| MORF Morphic Holding | Initiates: Buy | $75 | $29.33 | +155.71% | 1 | Jul 21, 2023 | |
| DNA Ginkgo Bioworks Holdings | Initiates: Buy | $6 | $0.89 | +571.59% | 1 | Nov 29, 2022 | |
| ME 23andMe Holding Co. | Initiates: Buy | $7 | $0.48 | +1,350.18% | 1 | Nov 29, 2022 | |
| CERT Certara | Initiates: Buy | $23 | $16.35 | +40.67% | 1 | Sep 8, 2022 | |
| ABSI Absci | Initiates: Buy | $28 | $4.94 | +466.80% | 1 | Feb 1, 2022 | |
| RLAY Relay Therapeutics | Initiates: Buy | $45 | $6.51 | +591.24% | 1 | Feb 1, 2022 |
Twist Bioscience
Sep 27, 2023
Initiates: Buy
Price Target: $27
Current: $41.40
Upside: -34.78%
Exscientia
Jul 21, 2023
Initiates: Buy
Price Target: $13
Current: $4.68
Upside: +177.78%
Morphic Holding
Jul 21, 2023
Initiates: Buy
Price Target: $75
Current: $29.33
Upside: +155.71%
Ginkgo Bioworks Holdings
Nov 29, 2022
Initiates: Buy
Price Target: $6
Current: $0.89
Upside: +571.59%
23andMe Holding Co.
Nov 29, 2022
Initiates: Buy
Price Target: $7
Current: $0.48
Upside: +1,350.18%
Certara
Sep 8, 2022
Initiates: Buy
Price Target: $23
Current: $16.35
Upside: +40.67%
Absci
Feb 1, 2022
Initiates: Buy
Price Target: $28
Current: $4.94
Upside: +466.80%
Relay Therapeutics
Feb 1, 2022
Initiates: Buy
Price Target: $45
Current: $6.51
Upside: +591.24%